Abstract
Introduced in the 1980s, carbapenem antibiotics have served as the last line of defense against multidrug-resistant Gram-negative organisms. Over the last decade, carbapenem-resistant Enterobacteriaceae (CRE) have emerged as a significant public health threat. This review summarizes the molecular genetics, natural history, and epidemiology of CRE and discusses approaches to prevention and treatment.
Original language | English |
---|---|
Pages (from-to) | 22-42 |
Number of pages | 21 |
Journal | Annals of the New York Academy of Sciences |
Volume | 1323 |
Issue number | 1 |
DOIs | |
State | Published - 1 Sep 2014 |
Keywords
- Antimicrobial resistance
- Carbapenem-resistant Enterobacteriaceae
- Carbapenemases
- Infection control
- Molecular genetics
- Treatment